Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,853-3,864 of 10,612

Drug study icon

CompletedNCT00349973

study of Dipyridamole in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

CompletedNCT00034229

study of Felbamate for Treatment-Resistant Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT04846868

study of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States, Australia, Canada, ...
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

Drug study icon

CompletedNCT04846881

study of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States, France, Argentina, ...
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

Drug study icon

CompletedNCT04985942

study of Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Czechia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Depression

Drug study icon

CompletedNCT00043654

study of Mifepristone for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00025792

study of Pramipexole in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT05892432

study of Rybelsus (Semaglutide) Among Adults With Addiction (AUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 21 Years

Countries: United States
Sponsor: University of Colorado, Denver
Condition: Addiction

Behavioral study icon

CompletedNCT02656745

study of Smoking Cessation Mobile Phone Program

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Click Therapeutics, Inc.
Condition: Addiction

Drug study icon

TerminatedNCT00044083

study of Tolcapone for Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00685178

study of Topiramate for Cocaine Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

Behavioral study icon

CompletedNCT02990793

study Safety and Efficacy of MeRT Treatment in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Wave Neuroscience
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.